This inventor holds 2 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Hiromi Kiyota: Innovator in Imidazole Derivatives
Introduction
Hiromi Kiyota is a notable inventor based in Nogi-machi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on imidazole derivatives. With a total of 2 patents, Kiyota's innovations are paving the way for advancements in selective antagonistic substances against muscarinic acetylcholine.
Latest Patents
One of Kiyota's latest patents focuses on imidazole derivatives and the process for preparing them. This invention relates to imidazole derivatives that serve as selective antagonistic substances against muscarinic acetylcholine. The patent provides a general formula for these derivatives, detailing various substituents and structural components that enhance their efficacy.
Career Highlights
Kiyota is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work is characterized by a commitment to advancing medical science through research and development.
Collaborations
Kiyota collaborates with talented individuals such as Hiroyuki Miyachi and Kei Okazaki, who contribute to the innovative environment at Kyorin Pharmaceutical Co., Ltd. Their teamwork fosters creativity and drives the development of new pharmaceutical products.
Conclusion
Hiromi Kiyota's contributions to the field of pharmaceuticals, particularly through his work on imidazole derivatives, highlight his role as an influential inventor. His ongoing research and collaborations promise to yield further advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
